Literature DB >> 25102500

Calcium carbonate powder containing gentamicin for mixing with bone grafts.

Débora Coraça-Huber, Johann Hausdorfer, Manfred Fille, Michael Nogler, Klaus-Dieter Kühn.   

Abstract

Bone grafts are used for reconstructing bone defects caused by implant-associated complications, trauma, and tumors. Surgery with bone allografts is complex and time consuming; therefore, it is prone to a higher infection rate (2.0%-2.5%). In the case of site infection, systemically administered antibiotics cannot reach the infected bone graft. This study evaluated the use of resorbable bone graft substitute powder (HERAFILL; Heraeus Medical GmbH, Wehrheim, Germany) as a bone void-filling material as well as an antibiotic carrier for mixing with bone grafts. The antibiotic activity of the bone chips mixed with HERAFILL powder was measured by drug release tests and bacterial susceptibility with Bacillus subtilis, Staphylococcus epidermidis, and Staphylococcus aureus. HERAFILL powder was added to the bone chips (bone chips/HERAFILL; w/w = 1:1), mixed with a spatula, and vortexed for 1 minute. Gentamicin base release was evaluated in phosphate-buffered saline for up to 7 days using B subtilis bioassay. Antimicrobial efficacy was tested with S aureus and S epidermidis. The average amount of gentamicin base released from bone chips mixed with HERAFILL at 0 to 12 hours was 99.66 mg/mL. On day 7, the gentamicin base released 0.42 mg/mL. The elution released from bone chips mixed with HERAFILL promoted the formation of a zone of inhibition on S epidermidis and S aureus plates. This study confirmed the capacity of bone grafts to act as antibiotic carriers once mixed with HERAFILL powder. Bone chips mixed with HERAFILL showed efficacy against S aureus and S epidermidis. Copyright 2014, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25102500     DOI: 10.3928/01477447-20140728-50

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  6 in total

1.  Osteoinduction and -conduction through absorbable bone substitute materials based on calcium sulfate: in vivo biological behavior in a rabbit model.

Authors:  D Pförringer; N Harrasser; H Mühlhofer; M Kiokekli; A Stemberger; M van Griensven; M Lucke; R Burgkart; A Obermeier
Journal:  J Mater Sci Mater Med       Date:  2018-01-09       Impact factor: 3.896

2.  Gentamycin elution from polymethylmethacrylate and bone graft substitute: Comparison between commercially available and home-made preparations.

Authors:  Makrina Karaglani; Evmorfia Tzitzikou; Stylianos Tottas; Ioannis Kougioumtzis; Konstantinos Arvanitidis; George Kolios; Ekaterini Chatzaki; Georgios I Drosos
Journal:  J Orthop       Date:  2019-11-27

3.  Antibiotic-loaded calcium carbonate/calcium sulfate granules as co-adjuvant for bone grafting.

Authors:  Débora C Coraça-Huber; Alexander Wurm; Manfred Fille; Johann Hausdorfer; Michael Nogler; S Vogt; Klaus-Dieter Kühn
Journal:  J Mater Sci Mater Med       Date:  2015-01-13       Impact factor: 3.896

4.  Silver nanoparticle based antibacterial methacrylate hydrogels potential for bone graft applications.

Authors:  M Isabel González-Sánchez; Stefano Perni; Giacomo Tommasi; Nathanael Glyn Morris; Karl Hawkins; Enrique López-Cabarcos; Polina Prokopovich
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2015-02-09       Impact factor: 7.328

5.  Lyophilized allogeneic bone tissue as an antibiotic carrier.

Authors:  Débora C Coraça-Huber; Christoph G Ammann; Michael Nogler; Manfred Fille; Lars Frommelt; Klaus-Dieter Kühn; Christian Fölsch
Journal:  Cell Tissue Bank       Date:  2016-09-08       Impact factor: 1.522

6.  Elution kinetics of vancomycin and gentamicin from carriers and their effects on mesenchymal stem cell proliferation: an in vitro study.

Authors:  Tomas Kucera; Lenka Ryskova; Tomas Soukup; Jana Malakova; Eva Cermakova; Pavel Mericka; Jakub Suchanek; Pavel Sponer
Journal:  BMC Musculoskelet Disord       Date:  2017-09-02       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.